LONDON February 28 2017 PRNewswire TxCell's novel CARmodified regulatory Tcell CAR Treg platform is developing well. CAR Tregs offer a powerful and versatile new approach to autoimmune and immune system disorders. TxCell has four indications in preclin...
↧